COVID-19 Linked in 3 Cases to Severe aHUS; All Treated With Soliris

COVID-19 Linked in 3 Cases to Severe aHUS; All Treated With Soliris

313803

COVID-19 Linked in 3 Cases to Severe aHUS; All Treated With Soliris

Some COVID-19 patients may develop severe atypical hemolytic uremic syndrome (aHUS), but it can be completely or partly resolved with Soliris (eculizumab), according to three cases reported in a recent study. These cases add to a few other aHUS cases reported to be likely triggered by COVID-19, further emphasizing the possibility of this complication amid the ongoing global pandemic. Data also suggests that Soliris and other anti-complement therapies may be beneficial for progressive COVID-19 with…

You must be logged in to read/download the full post.